These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16162168)

  • 1. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury.
    Lee HU; Bae EA; Han MJ; Kim NJ; Kim DH
    Liver Int; 2005 Oct; 25(5):1069-73. PubMed ID: 16162168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective effect of 20(S)-ginsenosides Rg3 and its metabolite 20(S)-ginsenoside Rh2 on tert-butyl hydroperoxide-induced liver injury.
    Lee HU; Bae EA; Han MJ; Kim DH
    Biol Pharm Bull; 2005 Oct; 28(10):1992-4. PubMed ID: 16204963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation.
    Joh EH; Lee IA; Jung IH; Kim DH
    Biochem Pharmacol; 2011 Aug; 82(3):278-86. PubMed ID: 21600888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rb1, A Major Saponin from
    Ren S; Leng J; Xu XY; Jiang S; Wang YP; Yan XT; Liu Z; Chen C; Wang Z; Li W
    Am J Chin Med; 2019; 47(8):1815-1831. PubMed ID: 31786947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotective effect of fermented ginseng and its major constituent compound K in a rat model of paracetamol (acetaminophen)-induced liver injury.
    Igami K; Shimojo Y; Ito H; Miyazaki T; Kashiwada Y
    J Pharm Pharmacol; 2015 Apr; 67(4):565-72. PubMed ID: 25495794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng.
    Akao T; Kida H; Kanaoka M; Hattori M; Kobashi K
    J Pharm Pharmacol; 1998 Oct; 50(10):1155-60. PubMed ID: 9821663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and -Rb2 in the digestive tract of rats.
    Karikura M; Miyase T; Tanizawa H; Taniyama T; Takino Y
    Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2357-61. PubMed ID: 1804549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in rats.
    Hou YL; Tsai YH; Lin YH; Chao JC
    BMC Complement Altern Med; 2014 Oct; 14():415. PubMed ID: 25344394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipruritic effect of ginsenoside rb1 and compound k in scratching behavior mouse models.
    Shin YW; Kim DH
    J Pharmacol Sci; 2005 Sep; 99(1):83-8. PubMed ID: 16141639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria.
    Bae EA; Park SY; Kim DH
    Biol Pharm Bull; 2000 Dec; 23(12):1481-5. PubMed ID: 11145182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of minor ginsenosides C-Mc, C-Y, F2, and C-K from American ginseng PPD-ginsenoside using special ginsenosidase type-I from Aspergillus niger g.848.
    Liu CY; Zhou RX; Sun CK; Jin YH; Yu HS; Zhang TY; Xu LQ; Jin FX
    J Ginseng Res; 2015 Jul; 39(3):221-9. PubMed ID: 26199553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoprotective effects of irisolidone on tert-butyl hyperoxide-induced liver injury.
    Lee HU; Bae EA; Kim DH
    Biol Pharm Bull; 2005 Mar; 28(3):531-3. PubMed ID: 15744084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenosides, ingredients of the root of Panax ginseng, are not substrates but inhibitors of sodium-glucose transporter 1.
    Gao S; Kushida H; Makino T
    J Nat Med; 2017 Jan; 71(1):131-138. PubMed ID: 27619505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins.
    Hasegawa H; Sung JH; Benno Y
    Planta Med; 1997 Oct; 63(5):436-40. PubMed ID: 9342949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide.
    Park EK; Shin YW; Lee HU; Kim SS; Lee YC; Lee BY; Kim DH
    Biol Pharm Bull; 2005 Apr; 28(4):652-6. PubMed ID: 15802804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin.
    Xu R; Peng Y; Wang M; Fan L; Li X
    J Ethnopharmacol; 2014 Dec; 158 Pt A():338-44. PubMed ID: 25446586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoprotective effect of tectoridin and tectorigenin on tert-butyl hyperoxide-induced liver injury.
    Lee HU; Bae EA; Kim DH
    J Pharmacol Sci; 2005 Apr; 97(4):541-4. PubMed ID: 15821336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals.
    Jeon JH; Lee J; Choi MK; Song IS
    Arch Pharm Res; 2020 Dec; 43(12):1335-1346. PubMed ID: 33225388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Korean red ginseng extract prevents APAP-induced hepatotoxicity through metabolic enzyme regulation: the role of ginsenoside Rg3, a protopanaxadiol.
    Gum SI; Cho MK
    Liver Int; 2013 Aug; 33(7):1071-84. PubMed ID: 23750847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of biotransformation and pharmacology of ginsenoside compound K.
    Yang XD; Yang YY; Ouyang DS; Yang GP
    Fitoterapia; 2015 Jan; 100():208-20. PubMed ID: 25449425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.